source
- Bayer wins FDA approval for stroke prevention drug SunharboBayer’s asundexian won FDA approval to reduce the risk of stroke in people who recently had a mild-to-moderate non-cardioembolic ischemic stroke or a high-risk transient ischemic attack. The agency…Endpoints · 54m ago↗ source
- Bayer's Sunharbo receives FDA approval as first Factor XIa blood thinnerFDA approved Bayer's new oral anticoagulant Sunharbo, marking the first U.S. approval of a Factor XIa inhibitor. The drug blocks Factor XIa, a protein that helps clots grow while playing a minor r…